Spatiotemporal analysis emphasizes value of vaccination

Spatiotemporal analysis emphasizes value of vaccination
Spatiotemporal data emphasizes the importance of vaccination programs, according to research published in the Nov. 28 issue of the New England Journal of Medicine.

(HealthDay)—Spatiotemporal data emphasizes the importance of vaccination programs, according to research published in the Nov. 28 issue of the New England Journal of Medicine.

Willem G. van Panhuis, M.D., Ph.D., from the University of Pittsburgh, and colleagues digitized all weekly surveillance reports of nationally notifiable diseases for U.S. cities and states published from 1888 to 2011 using data from the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report and its precursor journals. A detailed analysis was conducted, focusing on eight vaccine-preventable contagious diseases.

Assuming that the difference in before and after vaccine licensure was attributable solely to vaccination programs, the researchers estimate that vaccines prevented 103.1 million cases of contagious diseases since 1924. The number of cases prevented per disease varied with prevaccination incidence and the vaccine program duration, with the most cases prevented for diphtheria (about 40 million) followed by measles (about 35 million cases). In the years after vaccination, the proportion of cases of each disease prevented increased with varying rates. During the first five years after the licensure, 22.2 percent more cases were prevented each year. By year five after licensure, 95 percent of measles cases had been prevented, compared with year eight for polio, 19 years for diphtheria, and 17 years for pertussis. Since the 1980s, multiple resurgences of , rubella, mumps, and pertussis have occurred.

"Our analysis shows how high-resolution spatiotemporal data can be effectively used to illustrate these trends at the national and local levels and to inform public opinion about the necessity of vaccination programs," the authors write.

More information: Full Text (subscription or payment may be required)

Related Stories

Recommended for you

'Ebola will return', veteran scientist warns

date 8 hours ago

Congolese expert Jean-Jacques Muyembe may be little known to the public, but he has been one of the world's top Ebola investigators since the first epidemic erupted in central Africa in 1976.

Score IDs patients with upper extremity DVT at low risk

date 23 hours ago

(HealthDay)—For patients with upper-extremity deep vein thrombosis (DVT), six easily available factors can be used to create a score that identifies those at low risk of adverse events during the first ...

Combined drug treatment combats kidney disease

date May 29, 2015

A recent discovery by drug researchers whereby coupling specific cell membrane receptors has altered kidney cell function has triggered a re-think of how to treat chronic kidney disease (CKD) more effectively.

Active substance targeting dreaded hospital germs

date May 29, 2015

In the German Center for Infection Research (DZIF), scientists have conducted clinical studies on an active substance against the dreaded hospital pathogen Staphylococcus aureus: a highly effective protein from bacteriophages ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.